| Onyee Oche, | |
|
6856 Eastern Ave Nw, Washington, DC 20012-2165 | |
| (202) 541-9844 | |
| (202) 541-9845 |
| Full Name | Onyee Oche |
|---|---|
| Gender | Male |
| Speciality | Licensed Vocational Nurse |
| Location | 6856 Eastern Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235519547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | LPN1003983 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Onyee Oche, 6856 Eastern Ave Nw, Washington, DC 20012-2165 Ph: (202) 541-9844 | Onyee Oche, 6856 Eastern Ave Nw, Washington, DC 20012-2165 Ph: (202) 541-9844 |
News Archive
Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.
To date, it is not clear how the COVID-19 pandemic and implementation of various preventive strategies impacted mental health or which group of people were most affected by them. To address these issues, scientists have conducted coordinated analyses that included eleven UK longitudinal population studies, comprising data from before and throughout the pandemic.
Researchers have discovered an enzyme crucial to a type of DNA repair that also causes resistance to a class of cancer drugs most commonly used against ovarian cancer.Scientists from The University of Texas MD Anderson Cancer Center and the Life Sciences Institute of Zhejiang University in China report the discovery of the enzyme and its role in repairing DNA damage called cross-linking in the Science Express advance online publication of Science.
The American Association for Cancer Research will host a media forum focusing on new advancements in the prevention and patient management of cancer among women. This forum will be held here as part of the AACR's Ninth Annual Frontiers in Cancer Prevention Research Conference, which is Nov. 7-10, 2010.
Syndax, a clinical-stage epigenetics oncology company, announced publication of data of entinostat combined with the demethylating agent Vidaza® (azacitidine) showing effect in reducing tumor burden in differentiated tumor cells in animal tumor models of non-small cell lung cancer (NSCLC). The data is being published in the January 15, 2011 issue of Cancer Research.
› Verified 6 days ago
Timothy King Richguy Righteousness, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2811 Pennsylvania Ave Se, Washington, DC 20020 Phone: 202-894-6811 | |
Judith Chi, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2512 24th St Ne # Ll18a, Washington, DC 20018 Phone: 202-832-8340 Fax: 202-722-7785 | |
Prescilia Ndoping, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2512 24th St Ne, Washington, DC 20018 Phone: 202-832-8340 | |
Mrs. Karla Austin, NURSE/LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2112 F St Nw Ste 101, Washington, DC 20037 Phone: 301-974-1183 | |
Ruth Lagakingira, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1100 New Jersey Ave Se Ste 845, Washington, DC 20003 Phone: 202-545-6980 | |
Alice Fominyam, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1818 New York Ave Ne, 228, Washington, DC 20002 Phone: 202-832-8340 |